Sign in
4

Changes in Ownership

REPLIGEN CORP Filed Acc 0000899243-22-030728

Director sold 775 shares at $227.17 ($176,057)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
DAWES KAREN A Director 2022-09-09 Sale −775 $227.17 $176,057 76,401 D: show line 1 in the form
Open-market sales · 775 sh · avg $227.17 · $176,057
Loading xslF345X03/doc4.xml…